No Solid Evidence to Support GEP Testing in Thin Melanoma
Most studies that have looked at 31-GEP testing in melanoma have been retrospective or prospective, and did not involve a comparator group.
Skin Cancer
SKIN CANCER ADVISOR
FEATURED CONTENT
-
-
Neoadjuvant Nivolumab Appears Promising in Merkel Cell Carcinoma
A small phase 1/2 study shows high pCR rates. -
A New Look at the Dose-Response Relationship in Phase 1 Oncology Trials
The new generation of cancer drugs behave quite differently than cytotoxic therapies, and that may mean phase 1 trials need to be updated. -
Thyroid Dysfunction During Anti–PD‐1 Immunotherapy Linked to Better Survival Outcomes
There was no increase in survival linked to acquired subclinical thyroid dysfunction or preexisting thyroid dysfunction, however. -
NBUVB Phototherapy May Not Increase Skin Cancer Risk in Patients With Vitiligo
Many patients with vitiligo undergo multiple courses of phototherapy, which may raise concerns about their risk of photocarcinogenesis.
VIDEO SERIES
Recent Advances in Melanoma Therapy
Targeted Treatments and Immunotherapies for Melanoma
Tailoring Treatments in Melanoma
Drug Resistance in Melanoma
Affordability of Melanoma Care
Melanoma: Treatment-induced Toxicity
Immunotherapy: A Decade of Improvements in Melanoma
Should Patients With Melanoma Receive Targeted Therapy or Immunotherapy First?
Melanoma: Checkpoints in the Pipeline
Targeting Therapy for Melanoma Subtypes
Melanoma: Targetable Genes in the Pipeline
Clinical Trials in Melanoma
SKIN CANCER NEWS
Exposure to Antibiotics Associated With Survival Detriment in Patients With Advanced Melanoma Treated With ICIs
Continuous Dosing of BRAF/MEK Inhibition Superior to Intermittent Dosing in Melanoma
Atezolizumab Plus BRAF/MEK Inhibition Prolonged PFS in Melanoma
Keratinocyte Carcinoma Risk Factors in Allogeneic Hematopoietic Cell Transplant Recipients
Model Could Help Identify Who May Respond to Checkpoint Inhibition in Melanoma
Want to read more?
Please login or register first to view this content.
Next post in Skin Cancer
